C1-inhibitor therapy for hereditary angioedema attacks: Prospective patient assessments of health-related quality of life

Allergy and Asthma Proceedings

Volumn 33, Issue 5, 2012, Pages 427-431

  Bewtra, Againdra K ^a   Levy, Robyn J ^b   Jacobson, Kraig W ^c   Wasserman, Richard L ^d   Machnig, Thomas ^e   Craig, Timothy J ^f  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Family Allergy and Asthma Center   (United States)

^c Allergy and Asthma Research Group   (United States)

^d DallasAllergyImmunology   (United States)

^e CSL BEHRING GMBH   (Germany)

^f PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; PLACEBO;

ACUTE HEREDITARY ANGIOEDEMA; ADOLESCENT; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE MODIFICATION; MALE; MENTAL HEALTH; OPEN STUDY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SHORT FORM 12; SOCIAL INTERACTION; TREATMENT RESPONSE;

ACUTE DISEASE; ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; CHILD; COMPLEMENT C1 INHIBITOR PROTEIN; FEMALE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866772079     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3597     Document Type: Article

References (20)

1. Zuraw BL. Hereditary angioedema. N Engl J Med 359:1027-1036, 2008.
2. Frank MM. Hereditary angioedema: The clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 26:653-668, 2006. (Pubitemid 44666309)
3. Davis AE III. Hereditary angioedema: A current state-of-the-art review, III: Mechanisms of hereditary angioedema. Ann Allergy Asthma Immunol 100(suppl 2):S7-S12, 2008.
4. Bork K, Siedlecki K, Bosch S, et al. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 75:349-354, 2000. (Pubitemid 30187107)
5. Zuraw BL. Hereditary angioedema: A current state-of-the-art review, IV: Short- and long-term treatment of hereditary angioedema: Out with the old and in with the new? Ann Allergy Asthma Immunol 100(suppl 2):S13-S18, 2008.
6. Lumry WR, Castaldo AJ, Vernon MK, et al. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 31:407-414, 2010.
7. Bygum A, Andersen KE, and Mikkelsen CS. Self-administration of intravenous C1-inhibitor therapy for hereditary angioedema and associated quality of life benefits. Eur Dermatol 19:147-151, 2009.
8. Huang S-W. Results of an on-line survey of patients with hereditary angioedema. Allergy Asthma Proc 25:127-131, 2004. (Pubitemid 38639027)
9. Bernstein JA. Hereditary angioedema: A current state-of-the-art review, VIII: Current status of emerging therapies. Ann Allergy Asthma Immunol 100(suppl 2):S41-S46, 2008.
10. Gompels MM, Lock RJ, Abinun M, et al. C1 inhibitor deficiency: Consensus document. Clin Exp Immunol 139:379-394, 2005. (Pubitemid 40333248)
11. Bowen T, Cicardi M, Bork K, et al. Hereditary angioedema: A current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema. Ann Allergy Asthma Immunol 100(suppl 2):S30-S40, 2008.
12. Bork K, Meng G, Staubach P, and Hardt J. Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema. Transfusion 45:1774-1784, 2005. (Pubitemid 43923905)
13. Farkas H, Jakab L, Temesszentandrasi G, et al. Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy. J Allergy Clin Immunol 120:941-947, 2007. (Pubitemid 47531846)
14. Craig TJ, Levy RJ, Wasserman RL, et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 124:801-808, 2009.
15. Levy RL, Wasserman RL, Bewtra AK, et al. C1 esterase inhibitor concentrate (C1-INH) - Standard of care for the treatment of acute attacks of hereditary angioedema (HAE): Interim results of an ongoing, prospective, open-label study in North America after 640 attacks (I.M.P.A.C.T. 2). J Allergy Clin Immunol 123:S99, 2009.
16. Craig TJ, Bewtra AK, Bahna SL, et al. C1 esterase inhibitor concentrate in 1085 hereditary angioedema attacks - Final results of the I.M.P.A.C.T. 2 study. Allergy 66:1604-1611, 2011. (DOI: 10.1111/j. 1398-9995.2011.02702.x.)
17. Center for Outcomes Research, University of Massachusetts Medical School [Internet]. Interpretation guides to standardized questionnaires used in the ALS C.A.R.E database. Worcester (MA): University of Massachusetts; c1998-2010 [cited January 27, 2010]. Available from www.outcomes-umassmed.org/ALS/sf12.cfm. )
18. Craig TJ. Appraisal of danazol prophylaxis for hereditary angioedema. Allergy Asthma Proc 29:225-231, 2008.
19. Longhurst HJ, Carr S, and Khair K. C1-inhibitor concentrate home therapy for hereditary angioedema: A viable, effective treatment option. Clin Exp Immunol 147:11-17, 2006. (Pubitemid 44915550)
20. Levi M, Choi G, Picavet D, and Hack CE. Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol 117:904-908, 2006.